A misdiagnosed case of cancer leading to delayed HIV diagnosis and B-cell lymphoma: a lesson on the importance of timely HIV testing

1 Branson B. Current HIV epidemiology and revised recommendations for HIV testing in health-care settings. J Med Virol 2007;79 Suppl 1:S6-10. Search in Google Scholar

2 Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365(6):493-505. Search in Google Scholar

3 Tucker JD, Bien CH, Peeling RW. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr Opin Infect Dis 2013;26(1):73-9. Search in Google Scholar

4 Parczewski M, Rockstroh JK. Late HIV diagnosis: Where we stand and the way forward. HIV Med 2022;23(11):1115-7. Search in Google Scholar

5 Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338(13):853-60. Search in Google Scholar

6 Guidelines on HIV Self-Testing and Partner Notification: Supplement to Consolidated Guidelines on HIV Testing Services. Geneva: World Health Organization; 2016. Search in Google Scholar

7 EACS Guidelines 2022. https://www.eacsociety.org/media/guidelines-11.1_final_09-10.pdf (21.05.2023). Search in Google Scholar

8 Polish AIDS Society Recommendations. https://www.ptnaids.pl/index.php?option=com_content&view=article&id=20%3Arekomendacje-polskiego-towarzystwa-naukowego-aids&catid=14%3Arekomendacje&Itemid=24&lang=en (3.12.2023). Search in Google Scholar

9 Bull L, Rayment M. HIV-indicator-condition-driven HIV testing: clinically effective but still rarely implemented. Clin Med (Lond) 2016;16(2):175-9. Search in Google Scholar

10 HIV/AIDS surveillance in Europe 2015. European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe-2015 (18.06.2023). Search in Google Scholar

11 Suchacz MM, Krankowska D, Cybula A, Kamerys J, Jabłonowska E, Rozpłochowski B, et al. Delayed HIV diagnosis during the COVID-19 pandemic in Poland: A call for targeted HIV testing for those under suspicion of SARS-CoV-2. HIV Med 2022;23(11):1173-83. Search in Google Scholar

12 Kostaki EG, Limnaios S, Adamis G, Xylomenos G, Chini M, Mangafas N, et al. Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock-inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors. HIV Med 2022;23(11):1143-52. Search in Google Scholar

13 Gopal S, Patel MR, Yanik EL, Cole SR, Achenbach CJ, Napravnik S, et al. Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst 2013;105(16):1221-9. Search in Google Scholar

14 Besson C, Goubar A, Gabarre J, Rozenbaum W, Pialoux G, Châtelet FP, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001;98(8):2339-44. Search in Google Scholar

15 Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood 2015;125(15):2323-30. Search in Google Scholar

16 Powles T, Imami N, Nelson M, Gazzard BG, Bower M. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma. AIDS 2002;16(4):531-6. Search in Google Scholar

17 Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N, et al. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood 2013;122(19):3251-62. Search in Google Scholar

18 Mounier N, Spina M, Gabarre J, Raphael M, Rizzardini G, Golfier JB, et al. AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood 2006;107(10):3832-40. Search in Google Scholar

19 Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370(9581):59-67. Search in Google Scholar

20 Kirwan PD, Croxford S, Aghaizu A, Murphy G, Tosswill J, Brown AE, et al. Re-assessing the late HIV diagnosis surveillance definition in the era of increased and frequent testing. HIV Med 2022;23(11):1127-42. Search in Google Scholar

21 Aksak-Wąs BJ, Urbańska A, Leszczyszyn-Pynka M, Chober D, Parczewski M. Clinical parameters, selected HLA and chemokine gene variants associated with late presentation into care of people living with HIV/AIDS. Infect Genet Evol 2022;97:105180. Search in Google Scholar

22 Mocroft A, Lundgren J, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIVpositive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med 2013;10(9):e1001510. Search in Google Scholar

23 Jabłonowska E, Szetela B, Bielecki M, Horban A, Bociąga-Jasik M, Mularska E, et al. Acquired immune deficiency syndrome (AIDS) and late presentation in Poland – data from Test and Keep in Care (TAK) Polska project. HIV Med 2021;22(5):387-96. Search in Google Scholar

24 Aksak-Wąs BJ, Urbańska A, Scheibe K, Serwin K, Leszczyszyn-Pynka M, Rafalska-Kosior M, et al. Factors influencing immune restoration in people living with HIV/AIDS. J Clin Med 2022;11(7):1887. Search in Google Scholar

25 Aksak-Wąs BJ, Kowalska JD, Ząbek P, Serwin K, Rafalska-Kosior M, Gołąb J, et al. Immune restoration affects 10-year survival in people living with HIV/AIDS. HIV Med 2023;24(3):325-34. Search in Google Scholar

26 Yarchoan R, Uldrick TS. HIV-associated cancers and related diseases. N Engl J Med 2018;378(11):1029-41. Search in Google Scholar

27 Berhan A, Bayleyegn B, Getaneh Z. HIV/AIDS associated lymphoma: Review. Blood Lymphat Cancer 2022;12:31-45. Search in Google Scholar

28 Antinori A, Cingolani A, Alba L, Ammassari A, Serraino D, Palmieri F, et al. Better response to chemotherapy and prolonged survival in AIDSrelated lymphomas responding to highly active antiretroviral therapy. AIDS 2001;15(12):1483-91. Search in Google Scholar

29 Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008;123(1):187-94. Search in Google Scholar

30 Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97(6):425-32. Search in Google Scholar